One Health research programme: first grant recipients announced
The programme – The Bloomsbury SET: Connecting Capability to Combat the Threat from Infectious Disease and Antimicrobial Resistance – adopts a ‘one health’ approach to the development of new vaccines, diagnostic tools and mathematical models to combat infectious diseases and antimicrobial resistance.
Projects conducted by RVC academics were among two of the three recipients of this first tranche of grants. One is a project led by Professor Joanne Webster to examine the treatment of zoonotic hybrid and livestock schistosomiasis in sub-Saharan Africa, which has been awarded £280,274.
The second is a study led by Professor Dirk Werling, in collaboration with Professor Brendan Wren from the London School of Hygiene & Tropical Medicine (LSHTM), on the development and testing of a vaccine for Streptococcus suis, which has been awarded £333,604.
The third grant, valued at £350,776, was given to Professor Tim Allen of the London School of Economics & Political Science (LSE), and Professor Melissa Parker, of LSHTM, to help fund research into localised evidence and decision-making in the control and elimination of schistosomiasis in East Africa.
Welcoming the announcement of the awards, Professor Claire Heffernan, Professor of International Development and Director at LIDC, commented: “The Bloomsbury SET capitalises on our colleges’ world-leading expertise in infectious disease and supports our ability to transform research into tangible health outcomes for some of the most marginalised and vulnerable populations globally. By supporting early and mid-career researchers, The Bloomsbury SET also offers a pathway for the best ideas to merge into sustainable solutions.”
Dr Ray Kent, Director of Research Administration at the RVC, added: “These prestigious awards are the first in a series that is designed to demonstrate the benefits of connecting together the translational research capabilities of the four partner Colleges in The Bloomsbury SET. The projects funded in the first call for proposals have been selected on the basis of rigorous expert review. We anticipate they will make a significant contribution to the UK’s efforts in the fight against endemic and emerging infectious diseases.”
[SOURCE: Royal Veterinary College]